Income Statement
AETHLON MEDICAL INC
AEMD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | 0.00 | 0.57 | 0.29 | 0.66 | 0.65 | 0.23 | 0.15 | 0.39 | 0.89 | 1.62 | 1.23 | 1.36 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | 0.57 | 0.29 | 0.66 | 0.65 | 0.23 | 0.15 | 0.39 | 0.89 | 1.62 | 1.23 | 1.36 |
|
Operating Expenses
|
9.34 | 12.64 | 12.47 | 10.72 | 8.55 | 6.58 | 6.23 | 4.98 | 6.49 | 5.27 | 4.68 | 4.81 | 4.47 |
|
Research & Development
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Selling, General & Administrative
|
3.24 | 3.90 | 4.48 | 3.46 | 2.46 | 1.55 | 0.95 | 0.79 | 0.85 | 0.93 | 0.93 | 0.75 | 0.85 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-9.34 | -12.64 | -11.90 | -10.42 | -7.89 | -5.93 | -6.00 | -4.83 | -6.10 | -4.38 | -3.06 | -3.58 | -3.11 |
|
Non-Operating Income
|
- | - | - | - | 0.00 | -0.45 | - | - | - | - | 10.38 | 1.32 | -5.00 |
|
Interest Income
|
- | 0.43 | 0.01 | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
0.01 | - | - | - | - | 0.05 | 0.22 | 0.36 | 0.30 | - | 0.06 | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | -0.03 | -0.09 | -0.08 | - | - |
|
Net Income
|
-13.39 | -12.21 | -12.03 | -10.42 | -7.89 | -6.37 | -6.19 | -5.68 | -7.28 | -4.87 | -13.36 | -4.89 | -8.11 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-9.00 | -12.28 | -11.66 | -10.30 | -7.85 | -5.90 | -5.97 | -4.80 | -6.07 | -4.35 | -3.03 | -3.56 | -3.10 |
|
Earnings Per Share (Basic)
|
-0.27 | -0.49 | -0.59 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.27 | -0.49 | -0.59 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
1.56 | 2.51 | 20.54 | - | - | - | - | - | - | - | 194.06 | 149.22 | - |
|
Diluted Weighted Avg Shares
|
1.56 | 2.51 | 20.54 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-13.40 | -12.21 | -12.04 | - | - | - | - | - | - | - | - | - | - |